Baseline serum YKL-40 concentration was also significantly increased in patients with IPF compared to control subjects (65.20 (27.25-119.60) ng/ml vs. 22.35 (8.73-38.93) ng/ml; p < 0.001), see Figure 2. This evidence concerns the gene CHI3L1 and idiopathic pulmonary fibrosis.